Analysed ENVVENO MEDICAL CORP (NVNO:NASDAQ) News Sources
enVVeno Medical Presentation from H.C. Wainwright Conference Now Available On-Demand
11-09-2026
yahoo.com
enVVeno Medical Receives First-Ever FDA IDE Approval for a U.S. Pivotal Study of a Non-Surgical Replacement Venous Valve
29-04-2026
yahoo.com
enVVeno Medical Reports First Quarter 2026 Financial Results and Provides Business Update Highlighting Strategic Advancement of the enVVe System
07-05-2026
yahoo.com
enVVeno Medical Secures Transformational U.S. Patent for enVVe System, Strengthening Competitive Moat Ahead of Launch of Historic FDA Pivotal Trial
07-07-2026
yahoo.com
enVVeno Medical Highlights Newly Issued U.S. Patent Strengthening Competitive Position Ahead of Historic Pivotal Trial in Virtual Investor "What This Means" Segment
15-07-2026
yahoo.com
enVVeno Medical Reports Second Quarter 2026 Financial Results and Advances Towards FDA Pivotal Trial for First-in-Class Non-Surgical Replacement Venous Valve
31-07-2026
yahoo.com
What is the current price of ENVVENO MEDICAL CORP (NVNO:NASDAQ)?
The current price of ENVVENO MEDICAL CORP (NVNO:NASDAQ) is $11.52.
ENVVENO MEDICAL CORP (NVNO:NASDAQ) absolute price change since previous trading day?
The absolute price change of ENVVENO MEDICAL CORP (NVNO:NASDAQ) since the previous trading day is $0.4.
ENVVENO MEDICAL CORP (NVNO:NASDAQ) percentage price change since previous trading day?
The percentage price change of ENVVENO MEDICAL CORP (NVNO:NASDAQ) since the previous trading day is 3.5971%.
What is the most recent average sentiment score for ENVVENO MEDICAL CORP (NVNO:NASDAQ)?
The most recent average sentiment score for ENVVENO MEDICAL CORP (NVNO:NASDAQ) is 79 out of 100.
What is the most recent average sentiment for ENVVENO MEDICAL CORP (NVNO:NASDAQ)?
The most recent sentiment for ENVVENO MEDICAL CORP (NVNO:NASDAQ) is .
SEC-8K** Filing Available For ENVVENO MEDICAL CORP (NVNO:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.